FDA's Revised MAPP on Indication-Specific Guidances Tells Sponsors When to Seek Help

Drug Industry Daily
A A
Future FDA guidances on developing drugs for specific indications will include key milestones to help manufacturers set up their product development programs and guide potential talks with the review division.

To View This Article:

Login

Subscribe To Drug Industry Daily